跳至主要内容
临床试验/NCT01955759
NCT01955759Unknown早期 1 期

Pharmacologic Prophylaxis for Atrial Fibrillation Following Coronary By-Pass Surgery

Heart Center BH Tuzla1 个研究点 分布在 1 个国家目标入组 260 人开始时间: 2013年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
发起方
入组人数
260
试验地点
1
主要终点
atrial fibrillation

研究概览

简要总结

The aim of the study is to evaluate whether combined therapy with beta-blocker, amiodarone and statine is better than beta-blocker alone for the prevention of atrial fibrillation after coronary by-pass surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

性别
All
接受健康志愿者

入选标准

  • significant coronary disease, sinus rhythm

排除标准

  • valvular disease, former by-pass surgery

研究组 & 干预措施

beta blocker and amiodarone

Experimental

The inteventin will be that patients will receive beta blocker Bisoprolol in adjusted dose + Amiodarone per os starting 7 days before coronary by-pass surgery, 200 mg. x 3 tab, followed by 200 mg x 2 tab per os starting on the second postoperative day untill discharge

干预措施: Amiodarone tab 200 mg x 3 (Drug)

beta blocker and amiodarone

Experimental

The inteventin will be that patients will receive beta blocker Bisoprolol in adjusted dose + Amiodarone per os starting 7 days before coronary by-pass surgery, 200 mg. x 3 tab, followed by 200 mg x 2 tab per os starting on the second postoperative day untill discharge

干预措施: beta blockers Bisoprolol in adjusted dose (Drug)

beta blocker and statin

Experimental

The intervention will be that patients will receive beta blocker (Bisoprolol tab in adjusted dose)+ Rosuvastatin 20 mg. x 1 starting 7 days before coronary by-pass surgry untill discharge.

干预措施: rosuvastatin 20 mg tab x1 (Drug)

beta blocker and statin

Experimental

The intervention will be that patients will receive beta blocker (Bisoprolol tab in adjusted dose)+ Rosuvastatin 20 mg. x 1 starting 7 days before coronary by-pass surgry untill discharge.

干预措施: beta blockers Bisoprolol in adjusted dose (Drug)

beta blocker

Placebo Comparator

Patients will receive beta blocker (Bisoprolol tab in adjusted dose).

干预措施: beta blockers Bisoprolol in adjusted dose (Drug)

结局指标

主要结局

atrial fibrillation

时间窗: 10 days on average during hospital stay after coronary by-pass surgery

outcome will be number of patients free from atrial fibrillation.

次要结局

未报告次要终点

研究者

发起方
Heart Center BH Tuzla
申办方类型
Other
责任方
Principal Investigator
主要研究者

Enes Osmanović

Mr.med.sc.Dr Enes Osmanovic

Heart Center BH Tuzla

研究点 (1)

Loading locations...

相似试验

Atrial Fibrillation and By-pass Surgery | 临床试验